Veracyte works with multiple study types across four geographic areas, making trial management and visibility challenging. Hear how they gained visibility across their trial portfolio and drove greater consistency in trial management with Veeva eTMF and CTMS.
“The biggest value of Veeva eTMF and CTMS is visibility to our portfolio; including company sponsored studies, research collaborations, and investigator initiated studies.”
– Lori Lofaro, VP of Clinical Affairs, Veracyte
Learn how Radiometer utilized user satisfaction surveys to create a business case for eTMF and CTMS.